Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05841056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial

Study acronym: START-POAF
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 4 months later Aug 31, 2028 → Dec 31, 2030
Primary endpoint added 4 → 5 primary endpoints
See other at-risk trials from Population Health Research Institute

Record History

  1. Minor Eligibility criteria expanded, about 13 wordsv9 See this version in full on ClinicalTrials.gov ↗
  2. Notable Primary completion pushed from Aug 31, 2028 to Dec 31, 2030 Primary endpoint(s) modified · Completion pushed from Nov 30, 2028 to Mar 31, 2031v8 Show 2 more changesShow less
    • Primary endpoint(s) modified
    • Completion pushed from Nov 30, 2028 to Mar 31, 2031

    See this version in full on ClinicalTrials.gov ↗

  3. Notable Primary completion date: Jun 30, 2026 to Aug 31, 2028 Study sites: 1 to 2 · Completion date: Sep 30, 2026 to Nov 30, 2028v7 Show 2 more changesShow less
    • Study sites: 1 to 2
    • Completion date: Sep 30, 2026 to Nov 30, 2028
  4. Notable Primary completion date: Nov 30, 2025 to Jun 30, 2026 Completion date: Jan 30, 2026 to Sep 30, 2026v6 Show 1 more changeShow less
    • Completion date: Jan 30, 2026 to Sep 30, 2026
  5. Notable Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of May 31, 2024 to Jun 13, 2024v5 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of May 31, 2024 to Jun 13, 2024
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Start date: Feb 29, 2024 to May 31, 2024 Primary completion date: Sep 30, 2025 to Nov 30, 2025 · Completion date: Dec 30, 2025 to Jan 30, 2026v4 Show 2 more changesShow less
    • Primary completion date: Sep 30, 2025 to Nov 30, 2025
    • Completion date: Dec 30, 2025 to Jan 30, 2026
  2. Notable Start date: Nov 7, 2023 to Feb 29, 2024v3
  3. Notable Start date: Jun 30, 2023 to Nov 7, 2023 Eligibility criteria expanded, about 56 wordsv2 Show 1 more changeShow less
    • Eligibility criteria expanded, about 56 words

    See this version in full on ClinicalTrials.gov ↗

  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The START-POAF pilot study is a prospective, open-label two-arm, randomized controlled trial with blinded assessment of outcomes (PROBE). This pilot study will assess Atrial Fibrillation (AF) recurrence and burden in patients with new-onset AF following cardiac surgery.
Trial Details
NCT Number NCT05841056
Lead Sponsor Population Health Research Institute
Conditions Atrial Fibrillation New Onset
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov